2 October 2026 · MHRA
MHRA publishes September medicines advertising investigation decisions
Medical businessesRegulation & claims
The MHRA has published its advertising investigation decisions for September 2026. These concern adverts reported to have breached legislation on advertising medicines.
Why it matters
The decisions are relevant to regulatory oversight of medicines promotion and businesses responsible for advertising medicines.
Protect your practice
Summary for general information only — not legal, clinical or insurance advice.